CSL has announced a
$210m expansion of its CSL
Behring manufacturing site in
Broadmeadows, Melbourne, to
help meet growing demand for
its global critical care therapy,
albumin.
Creating 190 highly skilled
manufacturing jobs, the new facility
would contribute “significantly”
to CSL’s albumin global production
presently supplied from German
and Swiss plants, CSL said.The above article was sent to subscribers in Pharmacy Daily's issue from 09 Oct 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Oct 14
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.